Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Chinese Patent Office
QuintilesIMS
Accenture
Farmers Insurance
Julphar
Express Scripts
Fish and Richardson

Generated: February 17, 2019

DrugPatentWatch Database Preview

REMICADE Drug Profile

« Back to Dashboard

Summary for Tradename: REMICADE
Pharmacology for REMICADE

US Patents for REMICADE

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Sign Up Massachusetts Eye and Ear Infirmary (Boston, MA) ➤ Sign Up RX Orphan search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Sign Up UNIVERSITY OF TROMSO (Tromso, NO) ➤ Sign Up RX Orphan search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Sign Up SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for REMICADE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
233 5006-2015 Slovakia ➤ Sign Up PRODUCT NAME: IBRUTINIB; REGISTRATION NO/DATE: EU/1/14/945 20141023
93138 Luxembourg ➤ Sign Up PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326
CA 2017 00012 Denmark ➤ Sign Up PRODUCT NAME: IBRUTINIB, ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/14/945 C(2015)4704 20150707
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Covington
Deloitte
Mallinckrodt
Healthtrust
Fish and Richardson
Cantor Fitzgerald
Federal Trade Commission
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.